RTOG 1016: Cisplatin Still Standard for HPV-Related Oral Cancer RTOG 1016: Cisplatin Still Standard for HPV-Related Oral Cancer

Cisplatin plus radiation therapy was superior to cetuximab/radiation therapy for all endpoints, but toxicity burden is much higherMedscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news